Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 49Pancreatic Neoplasms 33Prostatic Neoplasms 31Brain Neoplasms 28Lung Neoplasms 26Neoplasm Metastasis 24Melanoma 21Carcinoma, Hepatocellular 20Breast Neoplasms 16Carcinoma, Renal Cell 12Colorectal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Neoplasms 9Small Cell Lung Carcinoma 7Urinary Bladder Neoplasms 5Recurrence 5Head and Neck Neoplasms 5Glioblastoma 5Adenocarcinoma of Lung 5Sarcoma 4Liver Neoplasms 4Kidney Neoplasms 4Uterine Cervical Neoplasms 3NSCLC 3Clear-cell metastatic renal cell carcinoma 3Cholangiocarcinoma 3Uveal Melanoma 2Unresectable Locally Recurrent Rectal Cancer 2Rectal Neoplasms 2Ovarian Neoplasms 2

Interventions

tremelimumab 1durvalumab 1Streptozocin 1Spironolactone 1Specimen Handling 1Radiosurgery 1Radiation 1Nivolumab 1Mercaptopurine 1Melphalan 1Magnetic Resonance Spectroscopy 1Leuprolide 1Ipilimumab 1Collagenases 1Clomipramine 1Carmustine 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Rare Diseases × Radiosurgery × Clear all
NCT00004659 2005-06-24

Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors

Office of Rare Diseases (ORD)

Phase 2 Unknown
40 enrolled
CNS

Brain Neoplasms, Genetic Diseases, Inborn, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡